Intech Investment Management »

Arcutis Biotherapeutics shares owned by Intech Investment Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Intech Investment Management from 13F filings

Historical chart of Intech Investment Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Intech Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Intech Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $345k 37k 9.30

More positions owned by Intech Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
Progressive Corporation (PGR)
Chipotle Mexican Grill (CMG)
Wal-Mart Stores (WMT)
Constellation Energy (CEG)
Netflix (NFLX)
Hca Holdings (HCA)

View all positions for Intech Investment Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Suvretta Capital Management
Rubric Capital Management
BlackRock
Frazier Life Sciences Management
Polar Capital Holdings
Vanguard Group
State Street Corporation
Morgan Stanley
Gilder, Gagnon, Howe & Co
Franklin Resources
UBS Group
D. E. Shaw & Co
Geode Capital Management
Ensign Peak Advisors

View all funds holding Arcutis Biotherapeutics